| Name | Title | Contact Details |
|---|
Arcfield is a leading provider of full lifecycle, mission-focused systems engineering and integration capabilities to the U.S. Intelligence Community, Department of Defense and other agencies. The company has more than 60 years of proven experience providing advanced engineering and analysis, IT and C5ISR capabilities to support our nation`s most critical national security missions. Headquartered in Chantilly, VA and with 16 offices around the world, Arcfield employs approximately 1,200 engineers, analysts, IT specialists, and other professionals who put our customers` missions first, helping them solve their most complex challenges through innovations in modeling, simulation and analysis, digital transformation and C5ISR.
Drawbridge is a premier provider of cybersecurity software and solutions to the alternative investment industry. Its proprietary platform helps firms manage their governance, risk, and compliance (GRC) requirements while combatting sophisticated cyber threats and third-party risks. Drawbridge`s platform connects business, compliance, and IT to empower firms to centralize and manage their most robust security programs, improve their risk profile and raise institutional capital. With a tested team focused on value delivery and an 800+ strong customer base, Drawbridge offers unmatched customer service and flexibility to help businesses proactively manage vulnerabilities, plan for growth, and reduce complexity.
Peakway is a San Francisco, CA-based company in the Computers and Electronics sector.
Grapevine Technology is a Fairfield, CT-based company in the Computers and Electronics sector.
Saama develops life science solutions that accelerate clinical and commercial development. Today, more than 50 biotech companies – including many of the top 20 pharmaceutical companies – use Saama`s award-winning Life Science Analytics Cloud (LSAC) platform to accelerate more than 1,500 studies, including the clinical trial led to the world`s first COVID-19 vaccine. LSAC`s rich applications facilitate unprecedented and authoritative oversight and automation of comprehensive clinical research data, enabling companies to file New Drug Application (NDAs) more efficiently and bring treatments to patients sooner.